Cronos Group (TSX:CRON) (NASDAQ:CRON) said Thursday that it has extended its cooperation with MediPharm Labs (TSX:LABS) (OTCQX:MEDIF). The two cannabis companies have disclosed a new supply deal. We don’t know the financial details yet, but the cooperation is being well received. At least, today it is, with Cronos stock currently trading in the green.
Here’s what we know.Cronos Stock: The Latest and Greatest
Cronos Group and MediPharm Labs have an existing relationship, with MediPharm signing a contract in May with CRON, agreeing to supply it with bulk resin and cannabis concentrates. And this ...
Get the latest marijuana stock news, cannabis on stock news on PotStockNews